deListed Australia
Any AUS or NZ company

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:



ASX Announcements (courtesy of ASX)


ASX, Legal & CGT Status


(updated at weekends)
Former (or subsequent) names
Shareholder links


Company details
Address: C/-DFK Collins Pty Ltd 477 Bridge Street Richmond, Victoria 3121
Tel:  +61 7 3901 0751 Fax: +61 7 3901 0751

Date first listed: 12/11/1993

Sector: Health Care Equipment & Services
Industry Group: XHJ
Activities: Providing complete solutions to healthcare for their clinical and sharps waste streams with a focus on infection control, OH&S and clinical education

Shareholders in this company should consider crystallising a capital loss in 2023/24 by selling their shares. This process is now much easier and quicker. It can be achieved online by entering transaction details here. While, this usually makes good economic sense we recommend you seek professional advice before buying or selling securities, your accountant is probably the best person.


the company, now GROWTH CAPITAL GROUP LIMITED, emerges from administration


company has been renamed GROWTH CAPITAL GROUP LIMITED and is still in external administration


the Deed Administrators are currently liaising with a Director of the company in relation to a potential variation of the Deed of Company Arrangement and convening of a shareholders meeting


delisted from the close of trading on Monday, 3 October 2016 pursuant to Listing rule 17.12.


we understand the company failed and was delisted following ASX's refusal of an extension to the 1 October 2016 relisting deadline


The Company has terminated the Term Sheet entered into with Brand TV Media Pty Ltd ("BTV") announced on 29 August 2016. The ASX has refused the Company an extension from the 1 October 2016 relisting deadline and as such the Company acknowledges that it is unable to satisfy the Indicative Timetable announced and relevant Conditions Precedent within the Term Sheet. The Company and BTV have executed a letter of settlement, terminating the Term Sheet which releases one another from all liabilities thereunder. The board of MDV is disappointed with this outcome.


Medivac Limited announces that the Company has on 26 August 2016 entered into a binding term sheet with the shareholders of Brand TV Media Pty Ltd in relation to the proposed acquisition of the entire equity interest in Brand TV Media Pty Ltd by the Company. The Proposed Acquisition will result in a Reverse Takeover of the Company as defined in Chapter 1 and 2 of the Listing Rules of ASX and is subject to, inter alia, the approval of the ASX and the approval of the shareholders of the Company at a general meeting of shareholders to be convened.


Under listing rule 17.6, any entity (if not already suspended) that had not paid its annual listing fees by close of business on Monday 22 August 2016 will have its securities suspended from official quotation before the commencement of trading on Tuesday 23 August 2016. The company has not paid its annual listing fees in respect of the year ending 30 June 2017 but the securities are already suspended from official quotation.


The company issues its Deed of Company Arrangement.


At the adjourned major meeting of creditors held on 17 June 2016, creditors resolved for the company to execute a DOCA and that deed administrators were appointed. On 8 July 2016, the company executed the DOCA and on 15 July 2016 the administrators executed the DOCA.


Richard Albarran, Brent Kijurina and Cameron Shaw are appointed Administrators of the Company


The following entity (Medivac Limited) has not paid their annual listing fees in respect of the year ending 30 June 2016 but the securities are already suspended from official quotation. Under listing rule 17.15, any entity that has not paid its annual listing fees as required by listing rule 16.5 by 5.00 pm AEST on Monday 31 August 2015 will be removed from the official list with effect from the close of trading on Monday 31 August 2015


The company has a capital raising initiative that has received a commitment for a total amount of $200,000 loan from sophisticated investors. The proceeds are to be used predominately to finalise the outstanding Half-Year and Annual Report and on-going corporate overheads.


provides a general update on the Company


The Board of Medivac Limited (Medivac or the Company) is pleased to announce that it has agreed to acquire a commercial property at Tuggerah NSW as the first step in building a property fund to be managed by the Company. Funding for the transaction will be by first mortgage finance (65%) and the balance in shares of Medivac. The property is leased to a major international corporate


the Board has therefore resolved to establish two new business units to assist in shortening its realisation cycle from investments and balance the Company's overall performance. The two new subsidiaries will focus on: ï‚· Private to public investment; and ï‚· Special situation and secured lending. Both of these areas have shorter investment cycles and easier valuation metrics. The Company will make further announcements detailing these opportunities as funding and transactions are finalised


advises that further to its announcement of 1 October 2013, the Company's 2013 Annual Report is pending finalisation, subject to the following items being completed:  Formal confirmation that the La Jolla facility will be extended for a twelve month period; this has been agreed in-principle by the parties, subject to payment commitments being settled;  Finalisation of a partly paid convertible note facility from a group of directors and major shareholders to support the Company's working capital requirements. This facility will provide up to $500,000 over the next two years. Two of the notes have been applied for by directors and will require shareholder approval, to be sought at the upcoming AGM


suspended from Official Quotation from the commencement of trading today 1 October 2013 following failure to lodge their Full Year Accounts for the period ended 30 June 2013 in accordance with Listing rules


The suspension of trading in the securities of Medivac Limited (the "Company") will be lifted prior to the commencement of trading on Thursday, 29 August 2013 in accordance with listing rule 17.9, following the payment of the Company" annual listing fees. Security Code: MDV


Under listing rule 17.6, any entity (if not already suspended) that had not paid its annual listing fees by close of business on Thursday 22 August 2013 is to be suspended from official quotation before the commencement of trading on Friday 23 August 2013. The company has failed to pay to ASX Limited their annual listing fees in respect of the year ending 30 June 2014 and consequently will be suspended from quotation immediately.


we understand that on or about this date the company consolidated its shares 1 for 20


shares reinstated to quotation following lodgement of the company's financial reports to 31 December 2005


shares suspended from quotation following failure to lodge with ASX, the company's financial reports to 31 December 2005


name changed from Nautilus Australia Limited

View ASX Announcements (courtesy of ASX)


Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.
Loading comments....  Most recent comments



I am an MDV Shareholder and so is my SMSF. The shares are worthless I guess now but how do I transfer my SMSF shares to myself just in case MDV rises from the Ashes?

15/12/2017 13:04:46
Company Updates
Post your comments here
Please read our Terms before posting comments.
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    12/03/2012Helen OwensOn market186,020$0.013$2,418
    28/02/2012Paul McPhersonOn market1,300,000$0.010$13,020
    20/12/2011Paul McPhersonOn market450,000$0.016$7,363
    31/08/2011Paul McPhersonOn market5,000,000$0.003$15,000

    Click here for the last 20 transactions all companies

    Directors & Executives (current)
    Luke ConnorDirector15/07/2016
    Dean ScookDirector15/07/2016
    Carol HardieDirector15/07/2016
    Michael HigginsonCompany Secretary

    Date of first appointment, title may have changed.

    SPECIAL NOTE: During May 2024 we are working to remove duplications in the Company Secretary role.

    Directors & Executives (former)
    Phillip PryorChairman07/08/201515/07/2016
    Rodger JohnstonManaging Director02/07/201215/07/2016
    Craig HitchinsExecutive Director30/04/201315/07/2016
    Robert CrossmanNon Exec Chairman29/07/201407/01/2015
    Peter ElliottNon Exec Director06/03/201430/07/2014
    Kieran HonourExecutive Chairman27/11/201229/07/2014
    John EvansIndependent Director01/12/200730/04/2013
    Paul McPhersonNon Exec Director14/08/200617/12/2012
    Reba MeagherNon Exec Director01/02/201127/11/2012
    Helen OwensNon Exec Director01/02/201127/11/2012

    Date of first appointment, title may have changed.